Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

MBP peptide analogues described as multiple sclerosis treatment

July 26, 1996

Yeda claims protein as potential autoimmune disease treatment

July 26, 1996

Chinoin describes new selegiline formulation

July 26, 1996

Raloxifene indicated for excess NPY associated disorders

July 26, 1996

Pierre Fabre reports 5-HT1A agonists

July 26, 1996

Duloxetine claimed for new indication

July 26, 1996

Positive safety profile reported on histamine H3 antagonist research

July 26, 1996

SEPA-ibuprofen formulation fares well in phase II trial

July 26, 1996

RPR describes tachykinin NK1 antagonists

July 26, 1996

BMDB shows antinociceptive activity in mouse model

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...